HK Stock Market Move | HORIZONROBOT-W (09660) rose nearly 14%, forming a "dual strong" pattern in the smart driving chip market. Company HSD continues to ramp up production.
Horizon Robotics - W (09660) rose nearly 14%, as of the time of publication, it rose by 13.3% to $4.09 Hong Kong dollars, with a turnover of $701 million Hong Kong dollars.
HORIZONROBOT-W(09660) rose by nearly 14%, reaching a 13.3% increase to 4.09 Hong Kong dollars, with a trading volume of 7.01 billion Hong Kong dollars.
On the news front, according to data from NE Times New Energy, the total installation of driving assistance domain control chips in domestic passenger cars reached 600,000 in April. Nvidia ranked first with over 300,000 installations and a market share of 50.9%; Horizon surpassed Huawei and Tesla to rise to second place with over 80,000 installations, accounting for 13.6%. Industry analysis believes that the driving assistance domain control chip market is now showing a pattern of "dual dominance", with international chip giants and domestic smart driving suppliers leading the way, and diversified camps coexisting for car manufacturers' self-developed solutions.
It is worth mentioning that Horizon's high growth is closely related to the full-stage layout and deployment of their Journey 6 series chips. The Journey 6 is the only series of computing solutions in China that can meet the mass production requirements of intelligent driving at all stages. It has already secured partnerships with over 25 car manufacturers and over 100 vehicle models, with over 40 models already in mass production and on the market. Meanwhile, Horizon's full-scene driving assistance system HSD, based on the Journey 6, is continuously being mass-produced and installed in vehicles, which will further boost chip shipments. Currently, HSD has partnerships with as many as 10 domestic and foreign car brands, with over 20 designated cooperative models.
Related Articles

HK Stock Market Move | PA GOODDOCTOR (01833) rose by more than 9%, the company continues to benefit from the deep synergy of the group under the empowerment of AI, and its operational capabilities continue to be optimized.

HK Stock Market Move | HENLIUS (02696) rose more than 13% in early trading. H Medicine has been approved for a new indication in the European Union, achieving full coverage of first-line treatment for core subtypes of lung cancer.

Orient: Foreign cosmetics market warms up while domestic products break through, the entire industry is moving towards a high-quality "value war."
HK Stock Market Move | PA GOODDOCTOR (01833) rose by more than 9%, the company continues to benefit from the deep synergy of the group under the empowerment of AI, and its operational capabilities continue to be optimized.

HK Stock Market Move | HENLIUS (02696) rose more than 13% in early trading. H Medicine has been approved for a new indication in the European Union, achieving full coverage of first-line treatment for core subtypes of lung cancer.

Orient: Foreign cosmetics market warms up while domestic products break through, the entire industry is moving towards a high-quality "value war."

RECOMMEND





